Evidence map›Paper›PMID 39484442›Full record

ArticlebioRxiv : the preprint server for biology2024

Pre-existing H1N1 immunity reduces severe disease with bovine H5N1 influenza virus.

Valerie Le Sage, Bailee D Werner, Grace A Merrbach, Sarah E Petnuch, Aoife K O'Connell, Holly C Simmons, Kevin R McCarthy, Douglas S Reed, Louise H Moncla, Disha Bhavsar and 5 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Valerie Le SageCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, PA.
Bailee D WernerCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, PA.
Grace A MerrbachCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, PA.
Sarah E PetnuchCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, PA.
Aoife K O'ConnellNational Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA.
Holly C SimmonsCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, PA.
Kevin R McCarthyCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0003-1016-6015
Douglas S ReedCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0003-0076-9023
Louise H MonclaDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA.
Disha BhavsarDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Florian KrammerDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Nicholas A CrosslandNational Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA.ORCID 0000-0003-3873-9188
Anita K McElroyCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, PA.
W Paul DuprexCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0003-1716-6376
Seema S LakdawalaDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0002-7679-2150

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00014 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2021 to 2025
$62.6M
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00015 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HENSLEY, SCOTT · 2021 to 2025
$50.7M
Practices CoreUC7AI180311 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI William Paul Duprex · 2023 to 2026
$13.2M
Role of preexisting immunity on airborne transmission of influenza virusesR01AI158484 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Seema S. Lakdawala · 2022 to 2026
$3.3M
Vectra Polaris Quantitative Pathology Imaging SystemS10OD030269 · OD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CROSSLAND, NICHOLAS ALEXANDER · 2021 to 2021
$402k
Ventana Discovery Ultra Research Autostainer: an Ex+ Core serviceS10OD026983 · OD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CROSSLAND, NICHOLAS ALEXANDER · 2019 to 2019
$207k
NIAID NIH HHS 75N93021C00014NIAID NIH HHS 75N93021C00015NIAID NIH HHS R01 AI158484NIAID NIH HHS UC7 AI180311NIH HHS S10 OD026983NIH HHS S10 OD030269
6 · The paper itself

Abstract

The emergence of highly pathogenic H5N1 avian influenza in dairy cattle herds across the United States has caused multiple mild human infections. There is an urgent need to understand the risk of spillover into humans. Here, we show that pre-existing immunity from the 2009 H1N1 pandemic influenza virus provided protection from mortality and severe clinical disease to ferrets intranasally infected with bovine H5N1. H1N1 immune ferrets exhibited a differential tissue tropism with little bovine H5N1 viral dissemination to organs outside the respiratory tract and significantly less H5N1 virus found in nasal secretions and the respiratory tract. Additionally, ferrets with H1N1 prior immunity produced antibodies that cross-reacted with H5N1 neuraminidase protein. Taken together, these results suggest that mild disease in humans may be linked to prior immunity to human seasonal influenza viruses.

Indexed as

bovine H5N1H1N1pdm09Influenza viruspathogenesispre-existing immunity

Identifiers

PMID39484442
PMCPMC11527028

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.